We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Correvio Pharma drew a complete response letter from the FDA for its atrial fibrillation treatment Brinavess (vernakalant) because of inadequate safety data. Read More
Avsola is approved for all Remicade indications, including moderate-to-severe rheumatoid arthritis, moderate-to-severe Crohn's Disease in adults and children, and ankylosing spondylitis. Read More
The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended five drugs for approval at its final meeting of the year, including two generics and a biosimilar. Read More
The FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee voted unanimously on Friday to support Horizon Pharma’s teprotumumab infusion to treat active thyroid eye disease (TED). Read More